Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Preferred Stock Series C [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020		$ 5,626		$ 5,886	$ 64,417,218	$ (55,791,914)	$ (39,334)		$ 8,597,482
Beginning balance, shares at Dec. 31, 2020		5,625,884		5,886,073
Net loss						(7,128,921)		(23,576)	(7,152,497)
Change in foreign currency translation							(45,727)		(45,727)
Issuance of Series B preferred stock with common stock in connection with sales made under private offerings		$ 950			949,050				950,000
Issuance of Series B preferred stock with common stock in connection with sales made under private offerings, shares		950,000
Issuance of Series B preferred stock in exchange for consulting, professional and other services		$ 75			74,925				75,000
Issuance of Series B preferred stock in exchange for consulting, professional and other services, shares		75,000
Exchange of convertible notes and accrued interest for Series B preferred stock		$ 2,564			2,561,611				2,564,175
Exchange of convertible notes and accrued interest for Series B preferred stock, shares		2,564,175
Exchange of Series B preferred stock for Series C preferred stock		$ (9,215)	$ 9,215
Exchange of Series B preferred stock for Series C preferred stock, shares		(9,215,059)	9,215,059
Exchange of convertible notes and accrued interest for Series C preferred stock			$ 85		85,165				85,250
Exchange of convertible notes and accrued interest for Series C preferred stock ,shares			85,200
Issuance of Series C preferred stock with common stock in connection with sales made under private offerings			$ 100		99,900				100,000
Issuance of Series C preferred stock with common stock in connection with sales made under private offerings, shares			100,000
Issuance of common stock in connection with sales made under public offerings				$ 2,771	10,312,553				10,315,324
Issuance of common stock in connection with sales made under public offerings, shares				2,771,084
Issuance of common stock in connection with the exercise of common stock purchase warrants				$ 106	(106)
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares				105,648
Issuance of common stock as compensation to employees, officers and/or directors				$ 158	426,288				426,446
Issuance of common stock as compensation to employees, officers and/or directors, shares				157,943
Issuance of common stock in exchange for consulting, professional and other services				$ 150	511,308				511,458
Issuance of common stock in exchange for consulting, professional and other services, shares				150,393
Issuance of common stock in connection with the issuance of convertible notes				$ 18	39,732				39,750
Issuance of common stock in connection with the issuance of convertible notes, shares				17,746
Issuance of common stock warrants in connection with the issuance of convertible notes					1,895,078				1,895,078
Issuance of common stock in connection with the acquisition of a business				$ 1,772	4,998,228				5,000,000
Issuance of common stock in connection with the acquisition of a business, shares				1,771,883
Conversion of convertible notes and accrued interest into common stock				$ 1,465	1,766,832				1,768,297
Conversion of convertible notes and accrued interest into common stock, shares				1,464,966
Recognition of beneficial conversion features related to convertible notes					318,616				318,616
Stock based compensation expense related to stock options					33,698				33,698
Ending balance, value at Sep. 30, 2021			$ 9,400	$ 12,326	88,490,096	(62,920,855)	(85,061)	(23,576)	25,482,330
Ending balance, shares at Sep. 30, 2021			9,400,259	12,325,736
Beginning balance, value at Jun. 30, 2021			$ 9,315	$ 9,560	79,454,922	(60,611,994)	(17,465)		18,844,338
Beginning balance, shares at Jun. 30, 2021			9,315,059	9,560,074
Net loss						(2,308,841)		(23,576)	(2,332,417)
Change in foreign currency translation							(67,596)		(67,596)
Exchange of convertible notes and accrued interest for Series C preferred stock			$ 85		85,165				85,250
Exchange of convertible notes and accrued interest for Series C preferred stock ,shares			85,200
Issuance of common stock in connection with sales made under public offerings				$ 361	1,361,347				1,361,708
Issuance of common stock in connection with sales made under public offerings, shares				361,445
Issuance of common stock as compensation to employees, officers and/or directors				$ 158	426,288				426,446
Issuance of common stock as compensation to employees, officers and/or directors, shares				157,943
Issuance of common stock in exchange for consulting, professional and other services				$ 86	255,011				255,097
Issuance of common stock in exchange for consulting, professional and other services, shares				86,522
Issuance of common stock in connection with the issuance of convertible notes				$ 5	9,995				10,000
Issuance of common stock in connection with the issuance of convertible notes, shares				4,464
Issuance of common stock warrants in connection with the issuance of convertible notes					1,200,434				1,200,434
Issuance of common stock in connection with the acquisition of a business				$ 1,772	4,998,228				5,000,000
Issuance of common stock in connection with the acquisition of a business, shares				1,771,883
Conversion of convertible notes and accrued interest into common stock				$ 384	665,008				665,392
Conversion of convertible notes and accrued interest into common stock, shares				383,405
Stock based compensation expense related to stock options					33,698				33,698
Ending balance, value at Sep. 30, 2021			$ 9,400	$ 12,326	88,490,096	(62,920,855)	(85,061)	(23,576)	25,482,330
Ending balance, shares at Sep. 30, 2021			9,400,259	12,325,736
Beginning balance, value at Dec. 31, 2021			$ 9,400	$ 12,698	89,851,309	(66,404,190)	(30,755)	2,682,339	26,120,801
Beginning balance, shares at Dec. 31, 2021			9,400,259	12,698,192
Net loss						(8,495,757)		(266,309)	(8,762,066)
Change in foreign currency translation							(129,361)		(129,361)
Preferred stock dividend payable on Series C preferred stock						(550,223)			(550,223)
Issuance of common stock in connection with Series C preferred stock dividend				$ 811	832,928				833,739
Issuance of common stock in connection with Series C preferred stock dividend, shares				810,975
Conversion of Series C preferred stock into common stock			$ (118)	$ 62	56
Conversion of Series C preferred stock into common stock, shares			(118,500)	61,719
Issuance of common stock in exchange for consulting, professional and other services				$ 178	116,558				116,736
Issuance of common stock in exchange for consulting, professional and other services, shares				178,490
Conversion of convertible notes and accrued interest into common stock				$ 8,813	5,766,187				5,775,000
Conversion of convertible notes and accrued interest into common stock, shares				8,812,921
Recognition of beneficial conversion features related to convertible notes					363,329				363,329
Stock based compensation expense related to stock options					226,091				226,091
Ending balance, value at Sep. 30, 2022			$ 9,282	$ 22,562	97,156,458	(75,450,170)	(160,116)	2,416,030	23,994,046
Ending balance, shares at Sep. 30, 2022			9,281,759	22,562,297
Beginning balance, value at Jun. 30, 2022			$ 9,361	$ 19,780	95,661,982	(73,253,212)	(87,776)	2,511,477	24,861,612
Beginning balance, shares at Jun. 30, 2022			9,360,759	19,780,053
Net loss						(2,010,795)		(95,447)	(2,106,242)
Change in foreign currency translation							(72,340)		(72,340)
Preferred stock dividend payable on Series C preferred stock						(186,163)			(186,163)
Issuance of common stock in connection with Series C preferred stock dividend				$ 459	186,757				187,216
Issuance of common stock in connection with Series C preferred stock dividend, shares				458,875
Conversion of Series C preferred stock into common stock			$ (79)	$ (41)	(38)
Conversion of Series C preferred stock into common stock, shares			(79,000)	41,146
Issuance of common stock in exchange for consulting, professional and other services				$ 60	21,194				21,254
Issuance of common stock in exchange for consulting, professional and other services, shares				60,000
Conversion of convertible notes and accrued interest into common stock				$ 2,222	1,197,778				1,200,000
Conversion of convertible notes and accrued interest into common stock, shares				2,222,223
Stock based compensation expense related to stock options					88,709				88,709
Ending balance, value at Sep. 30, 2022			$ 9,282	$ 22,562	$ 97,156,458	$ (75,450,170)	$ (160,116)	$ 2,416,030	$ 23,994,046
Ending balance, shares at Sep. 30, 2022			9,281,759	22,562,297